Weather Alert
Snow is in the forecast. Consider switching to a virtual visit to receive care from home. Learn more >>
Popular Search Terms
Leslie Benson, MD
Assistant Director, Pediatric Multiple Sclerosis and Related Disorders Program; Co-Director, Pediatric Neuroimmunology Center; Neurologist, Department of Neurology
Assistant Professor of Neurology, Harvard Medical School
Image
Leslie Benson, MD
Assistant Director, Pediatric Multiple Sclerosis and Related Disorders Program; Co-Director, Pediatric Neuroimmunology Center; Neurologist, Department of Neurology
Assistant Professor of Neurology, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Colorado State University
2002
Fort Collins
CO
Medical School
University of Colorado Health Sciences Center
2006
Denver
CO
Internship
Pediatrics
Massachusetts General Hospital for Children
2008
Boston
MA
Residency
Pediatric Neurology
Boston Children's Hospital
2011
Boston
MA
Fellowship
Boston Children's Hospital, Partners Adult MS Center at Brigham and Women's Hospital and Partners
Pediatric MS Center at Massachusetts General Hospital
2013
Boston
MA
Media
Caregiver Profile
Meet Dr. Leslie Benson
Certifications
American Board of Psychiatry and Neurology (Child and Adolescent Neurology)
Publications
Childhood adversity in parents of patients with pediatric multiple sclerosis. View Abstract
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. View Abstract
Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis. View Abstract
Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. View Abstract
Distinct plasma lipids predict axonal injury and multiple sclerosis activity. View Abstract
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. View Abstract
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. View Abstract
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis. View Abstract
Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. View Abstract
Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. View Abstract
Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. View Abstract
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. View Abstract
Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. View Abstract
Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset. View Abstract
Characteristics and predictors of disease course in children initially presenting with ADEM. View Abstract
Disease modifying treatment for pediatric onset multiple sclerosis: Ethical considerations and strategies to navigate parental refusal. View Abstract
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): a collaborative review of the current understanding. View Abstract
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. View Abstract
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. View Abstract
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. View Abstract
Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. View Abstract
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. View Abstract
MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. View Abstract
A new look at cognitive functioning in pediatric MS. View Abstract
Challenges in the Clinical Recognition of Acute Flaccid Myelitis and its Implications. View Abstract
Evaluation of white matter microstructure in pediatric onset multiple sclerosis with diffusion compartment imaging. View Abstract
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. View Abstract
ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD. View Abstract
Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. View Abstract
Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. View Abstract
Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis. View Abstract
Child Neurology: Recurrent Brainstem Strokes and Aphthous Ulcers in a Child With Mutations in the ADA2 Gene. View Abstract
Author Correction: Pan-viral serology implicates enteroviruses in acute flaccid myelitis. View Abstract
Gut microbiome is associated with multiple sclerosis activity in children. View Abstract
Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. View Abstract
Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population. View Abstract
Acute flaccid myelitis: cause, diagnosis, and management. View Abstract
Acute Flaccid Myelitis: A Call for Vigilance and an Update on Management. View Abstract
Improved relapse recovery in paediatric compared to adult multiple sclerosis. View Abstract
Pediatric Multiple Sclerosis Severity Score in a large US cohort. View Abstract
Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. View Abstract
Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. View Abstract
Pan-viral serology implicates enteroviruses in acute flaccid myelitis. View Abstract
Unmet Needs in the Evaluation, Treatment, and Recovery for 167 Children Affected by Acute Flaccid Myelitis Reported by Parents Through Social Media. View Abstract
miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. View Abstract
Vitamin D genes influence MS relapses in children. View Abstract
Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. View Abstract
Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. View Abstract
Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. View Abstract
Clinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016. View Abstract
Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. View Abstract
Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. View Abstract
Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children. View Abstract
Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System. View Abstract
Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. View Abstract
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. View Abstract
Several household chemical exposures are associated with pediatric-onset multiple sclerosis. View Abstract
Urban air quality and associations with pediatric multiple sclerosis. View Abstract
Heterogeneity in association of remote herpesvirus infections and pediatric MS. View Abstract
Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. View Abstract
Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. View Abstract
Genetic risk factors for pediatric-onset multiple sclerosis. View Abstract
Examining the contributions of environmental quality to pediatric multiple sclerosis. View Abstract
Dietary factors and pediatric multiple sclerosis: A case-control study. View Abstract
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. View Abstract
Investigations in GABAA receptor antibody-associated encephalitis. View Abstract
Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. View Abstract
Pediatric optic neuritis. View Abstract
Characteristics of Children and Adolescents With Multiple Sclerosis. View Abstract
Dietary salt intake and time to relapse in paediatric multiple sclerosis. View Abstract
A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. View Abstract
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder. View Abstract
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. View Abstract
Pain and spinal cord imaging measures in children with demyelinating disease. View Abstract
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. View Abstract
Reply: To PMID 24907434. View Abstract
Evaluation and treatment of autoimmune neurologic disorders in the pediatric intensive care unit. View Abstract
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. View Abstract
Visual outcomes in pediatric optic neuritis. View Abstract
Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis. View Abstract
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. View Abstract
Functional relapses in pediatric multiple sclerosis. View Abstract
Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. View Abstract
New onset epilepsy in Prader-Willi syndrome: semiology and literature review. View Abstract
Characterization of selected elementary motion detector cells to image primitives. View Abstract
Locations